| Crystal structure of human FPPS in complex with YS_04_70 | | homo-2-mer | 74-419 | 100 | 2×YS4; 6×MG; |
|
| Crystal structure of human FPPS in complex with magnesium and JDS05120 | | homo-2-mer | 74-419 | 100.0 | 2×JD5; 6×MG; |
|
| Crystal structure of human FPPS in ternary complex with YS0470 and inorganic phosphate | | homo-2-mer | 74-419 | 100 | 2×YS4; 2×PO4; 6×MG; |
|
| Crystal structure of human FPPS in ternary complex with YS0470 and inorganic pyrophosphate | | homo-2-mer | 74-419 | 100 | 2×YS4; 2×POP; 6×MG; |
|
| Crystal structure of human FPPS in ternary complex with YS0470 and isopentenyl pyrophosphate | | homo-2-mer | 74-419 | 100 | 2×YS4; 2×IPR; 6×MG; |
|
| Crystal structure of human FPPS in complex with [({5-[4-(propan-2-yloxy)phenyl]pyridin-3-yl}amino)m… | | homo-2-mer | 74-419 | 100 | 6×MG; 2×JD1; 2×GOL; |
|
| Crystal Structure of Human Farnesyl Diphosphate Synthase in Complex with BPH-1260 | | homo-2-mer | 74-419 | 100 | 2×4GA; 6×MG; 4×PO4; |
|
| Crystal structure of human farnesyl diphosphoate synthase in complex with zoledronate and taxodione | | homo-2-mer | 74-419 | 100 | 2×ZOL; 2×1WO; 6×MG; |
|
| Human farnesyl diphosphate synthase in complex with Arenarone and zoledronate | | homo-2-mer | 74-419 | 100 | 2×1XH; 2×ZOL; 6×MG; |
|
| Crystal structure of human FPPS in complex with magnesium, CL02134, and inorganic pyrophosphate | | homo-2-mer | 74-419 | 100 | 2×YL2; 2×POP; 6×MG; |
|
| Crystal structure of human FPPS in complex with pamidronate | | homo-2-mer | 74-419 | 100 | 2×PO4; 6×MN; 2×210; |
|
| Crystal structure of human FPPS in complex with zoledronate and isopentenyl diphosphate | | homo-2-mer | 74-419 | 100 | 6×MG; 2×IPE; 2×ZOL; |
|
| Crystal Structure of Human Farnesyl Pyrophosphate Synthase (Y204F) Mutant Complexed with Mg, Risedr… | | homo-2-mer | 75-419 | 99.71 | 6×MG; 2×IPE; 2×RIS; |
|
| Crystal Structure of Farnesyl Pyrophosphate Synthase Mutant (Y204A) Complexed with Mg, Risedronate … | | homo-2-mer | 75-419 | 99.71 | 6×MG; 2×IPE; 2×RIS; |
|
| Crystal structure of human FPPS in complex with salicylic acid derivative 3a | | homo-2-mer | 74-418 | 100 | 4×GOL; 2×5B9; 2×MG; 2×PO4; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037 | | homo-2-mer | 73-416 | 100.0 | 2×YL6; 2×PO4; 4×CL; |
|
| Crystal Structure of Farnesyl Synthase Mutant (Y204A) Complexed with Mg, Alendronate and Isopenteny… | | homo-2-mer | 76-419 | 99.71 | 6×MG; 2×IPE; 2×AHD; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02-78 | | homo-2-mer | 73-416 | 100.0 | 2×GOL; 4×M2V; 2×PO4; |
|
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | | homo-2-mer | 76-419 | 99.71 | 6×MG; 2×IPE; 2×RIS; |
|
| Human FPPS complex with FBS_04 and zoledronic acid/MG2+ | | homo-2-mer | 74-416 | 100 | 2×3N3; 2×ZOL; 6×MG; 4×PO4; |
|
| Human farnesyl diphosphate synthase complexed with MG and minodronate | | homo-2-mer | 74-416 | 100 | 8×MG; 2×M0N; |
|
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | | homo-2-mer | 74-416 | 99.41 | 6×MG; 2×210; 2×EDO; 2×PEG; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037 | | homo-2-mer | 74-416 | 100.0 | 2×GOL; 4×YF7; 2×PGE; 2×EDO; 4×CL; 2×PO4; |
|
| Crystal structure of human FPPS in complex with magnesium, JDS05120, and sulfate | | homo-2-mer | 74-416 | 100 | 2×JD5; 6×MG; 2×SO4; |
|
| Crystal structure of human FPPS in complex with Zoledronate and Zn2+ | | homo-2-mer | 74-416 | 100 | 6×ZN; 2×PO4; 2×ZOL; |
|
| Crystal structure of human FPPS in complex with compound 13 | | homo-2-mer | 74-416 | 100 | 2×59Y; |
|
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | | homo-2-mer | 74-416 | 99.41 | 6×MG; 2×IPE; 2×210; |
|
| Human FDPS Synthase in Complex with a N-Methyl Pyridinum Bisphosphonate | | homo-2-mer | 74-416 | 100.0 | 2×UNR; 6×MG; 2×SO4; |
|
| Crystal structure of human FPPS in complex with alendronate | | homo-2-mer | 74-416 | 100 | 6×ZN; 2×PO4; 2×AHD; |
|
| Human FPPS COMPLEX WITH FBS_01 | | homo-2-mer | 74-416 | 100 | 4×3N1; 2×PO4; |
|
| Crystal structure of human FPPS in complex with [({4-[4-(cyclopropyloxy)phenyl]pyridin-2-yl}amino)m… | | homo-2-mer | 74-416 | 100 | 6×MG; 2×YS1; 2×GOL; |
|
| Human fpps complex with NOV_304 | | homo-2-mer | 74-416 | 100 | 4×GO0; 2×PO4; |
|
| Crystal structure of FPPS in complex with Zoledronate | | homo-2-mer | 74-416 | 100 | 2×PO4; 6×MG; 2×ZOL; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02-82 | | homo-2-mer | 74-416 | 100 | 4×M2Y; 2×PO4; |
|
| Crystal structure of human FPPS in complex with biaryl compound 8e | | homo-2-mer | 74-416 | 100 | 2×5BL; |
|
| Human FPPS complex with NOV_980 and zoledronic acid/MG2+ | | homo-2-mer | 74-416 | 100 | 2×3N5; 2×ZOL; 6×MG; 2×PO4; |
|
| Human fpps complex with NOV_311 | | homo-2-mer | 74-416 | 100 | 4×GO1; 2×PO4; |
|
| Crystal structure of human FPPS in complex with biaryl compound 5 | | homo-2-mer | 74-416 | 100 | 2×5BJ; 2×PO4; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor CL-08-038 | | homo-2-mer | 74-416 | 100.0 | 4×SO4; 6×YL5; |
|
| Human FPPS COMPLEX WITH NOV_292 | | homo-2-mer | 74-416 | 100 | 2×3N4; 2×PO4; |
|
| Human FPPS COMPLEX WITH FBS_02 | | homo-2-mer | 74-416 | 100 | 2×3N2; 2×PO4; |
|
| Crystal structure of human FPPS in complex with the monophosphonate compound 15 | | homo-2-mer | 74-416 | 100 | 2×5A7; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor AM-02-072 | | homo-2-mer | 75-417 | 100.0 | 2×PO4; 4×7AM; |
|
| Human FPPS complex with FBS_03 | | homo-2-mer | 74-416 | 100 | 4×MS0; 2×PO4; |
|
| Crystal structure of human FPPS in complex with magnesium, CL01131, and sulfate | | homo-2-mer | 74-416 | 100 | 2×1MV; 2×SO4; 6×MG; |
|
| Crystal structure of human FPPS in complex with monophosphonate compound 7 | | homo-2-mer | 74-416 | 100 | 2×59Z; 2×PO4; |
|
| Neutron crystal structure of human farnesyl pyrophosphate synthase in complex with risedronate | | homo-2-mer | 74-416 | 100 | 6×MG; 2×RIS; |
|
| Neutron crystal structure of human farnesyl pyrophosphate synthase in complex with risedronate and … | | homo-2-mer | 74-416 | 100 | 6×MG; 2×RIS; 2×IPE; |
|
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | | homo-2-mer | 75-416 | 99.11 | 2×RIS; 6×MG; 12×EDO; 2×PO4; |
|
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | | homo-2-mer | 75-416 | 99.41 | 6×MG; 2×RIS; 2×IPE; 4×EDO; |
|
| New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by a… | | homo-2-mer | 75-416 | 100.0 | 2×39L; 6×MG; |
|
| Crystal structure of human farnesyl pyrophosphate synthase T210S mutant bound to risedronate | | homo-2-mer | 74-415 | 99.71 | 6×MG; 2×RIS; |
|
| Crystal structure of human FPPS in complex with nickel, JDS05120, and sulfate | | homo-2-mer | 74-415 | 100 | 6×NI; 2×JD5; 2×SO4; |
|
| Crystal structure of human FPPS in complex with ibandronate | | homo-2-mer | 74-415 | 100 | 6×ZN; 2×PO4; 2×BFQ; |
|
| Crystal Structure of Farnesyl Pyrophosphate Synthase (Y204A) Mutant complexed with Mg, Pamidronate | | homo-2-mer | 75-416 | 99.7 | 2×210; 6×MG; 12×EDO; |
|
| Human FDPS Synthase in Complex with a Rigid Analog of Risedronate | | homo-2-mer | 74-415 | 100.0 | 2×UNV; 6×MG; 2×SO4; |
|
| Crystal structure of human farnesyl pyrophosphate synthase (t201a mutant) complexed with mg and zol… | | homo-2-mer | 75-416 | 99.7 | 6×MG; 2×ZOL; 2×EDO; |
|
| Crystal structure of human FPPS in complex with YS0470 and two molecules of inorganic phosphate | | homo-2-mer | 74-415 | 100 | 2×YS4; 4×PO4; 6×MG; 2×CL; |
|
| Human FDPS synthase in complex with novel inhibitor | | homo-2-mer | 74-415 | 100.0 | 2×MG; 2×SO4; 2×11P; |
|
| Human FDPS synthase in complex with minodronate | | homo-2-mer | 75-416 | 100.0 | 2×M0N; 6×MG; |
|
| The role of lysine 200 in the human farnesyl pyrophosphate synthase catalytic mechanism and the mod… | | homo-2-mer | 74-415 | 99.41 | 6×MG; 2×RIS; 4×EDO; |
|
| Crystal structure of human FPPS in complex with CL03093 | | homo-2-mer | 74-415 | 100 | 2×PO4; 2×YL3; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor CL-08-066 | | homo-2-mer | 75-416 | 100.0 | 4×SO4; 4×YL6; |
|
| Crystal structure of human FPPS in complex with CL01131 | | homo-2-mer | 74-415 | 100.0 | 2×PO4; 2×1MV; |
|
| Crystal Structure of Human Farnesyl Pyrophosphate Synthase Mutant (Y204A) Complexed with Mg and Zol… | | homo-2-mer | 75-416 | 99.71 | 6×MG; 2×ZOL; 2×EDO; |
|
| Crystal structure of human FPPS in complex with biaryl compound 6 | | homo-2-mer | 75-416 | 100 | 4×GOL; 2×5BK; 2×PO4; |
|
| Crystal structure of human FPPS in complex with WC01088 | | homo-2-mer | 76-416 | 100 | 4×PO4; 2×WC1; 2×GOL; |
|
| Crystal structure of human FPPS with allosterically bound FPP | | homo-2-mer | 76-416 | 100.0 | 2×PO4; 2×FPP; |
|
| The role of threonine 201 and tyrosine 204 in the human farnesyl pyrophosphate synthase catalytic m… | | homo-2-mer | 75-415 | 99.7 | 2×RIS; 6×MG; 2×SO4; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor MIT-01-102 | | homo-2-mer | 76-416 | 100.0 | 2×GOL; 2×KFA; 2×PO4; |
|
| Crystal structure of unliganded human FPPS at 2.15 angstrom resolution | | homo-2-mer | 75-415 | 100 | 2×PO4; |
|
| Human FPPS complex with NOV_823 | | homo-2-mer | 76-416 | 100 | 2×BFH; 2×PO4; |
|
| Crystal Structure of Unliganded Human FPPS | | homo-2-mer | 75-415 | 100 | 2×PO4; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor MIT-01-055 | | homo-2-mer | 76-416 | 100.0 | 2×PO4; 4×CL; 4×6O3; |
|
| X-ray structure of Farnesyl diphosphate synthase protein | | homo-2-mer | 79-419 | 100.0 | 6×MG; 2×IPE; 2×ZOL; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor CL-06-057 | | homo-2-mer | 76-416 | 100.0 | 4×CL; 2×YL4; |
|
| Crystal Structure of Human Farnesyl Diphosphate Synthase in Complex with BPH-1222 | | homo-2-mer | 75-414 | 100.0 | 4×PO4; 6×MG; 2×N1Z; |
|
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037 | | homo-2-mer | 77-416 | 100.0 | 2×GOL; 2×KF7; 2×CL; |
|
| Crystal structure of human FPPS in complex with three magnesium ions | | homo-2-mer | 77-415 | 100 | 6×MG; 4×SO4; |
|
| Crystal structure of human farnesyl diphosphate synthase in complex with BPH-1358 | | homo-2-mer | 78-416 | 100.0 | 2×3F2; 2×PO4; |
|
| Crystal structure of human FPPS in complex with one magnesium ion | | homo-2-mer | 77-415 | 100 | 2×MG; 4×SO4; |
|
| Human farnesyl diphosphate synthase in complex with Taxodione | | homo-2-mer | 77-415 | 100.0 | 4×1WO; |
|
| Crystal structure of human farnesyl diphosphate synthase (T201A mutant) complexed with Mg and bipho… | | homo-2-mer | 77-414 | 99.7 | 6×MG; 2×RSX; |
|
| Human farnesyl diphosphate synthase complexed with Mg and risedronate | | homo-2-mer | 79-416 | 100.0 | 6×MG; 4×PO4; 2×RIS; |
|
| Human Farnesyl Diphosphate Synthase Complexed with Bisphosphonate BPH-461 | | homo-2-mer | 79-416 | 100.0 | 4×PO4; 6×MG; 2×NI9; |
|
| Human Farnesyl Diphosphate Synthase Complexed with Bisphosphonate BPH-527 | | homo-2-mer | 79-416 | 100.0 | 6×MG; 4×PO4; 2×SUF; |
|
| Human farnesyl diphosphate synthase complexed with risedronate | | homo-2-mer | 79-415 | 100.0 | 6×MG; 4×PO4; 2×RIS; |
|
| Crystal structure of human FPPS in complex with an inhibitor THZ93 | | monomer | 74-415 | 100.0 | 2×PO4; 3×MG; 1×T93; |
|